Healthspan taxonomy seed — see taxonomy_path
Current stock research snapshot · 7/31/26 28 days old
PRMEPrime Medicine
Investment conviction●●○○○2 of 5 · current snapshot
Research target$12.18Current stock price target
Investment thesis statusNEEDS_MORE_DATALast reviewed 7/31/26
Market cap$547MSnapshot value · 7/31/26
Prime Medicine prime editing pipeline; Q2 2026 earnings; IND/regulatory milestones for lead candidate(s); preclinical data for rare disease programs
needs primary source validation — pending deep-dive research. Placeholder: (1) thesis chain breaks on primary-source evidence, (2) named revenue/customer concentration risk, (3) margin compression or competitive displacement
Bullish — 35M short interest noted with potential BMY milestone or aatd/CF partnership; weekly chart 'tick tock'. [X search Aug 2026]
Snapshot · 7/31/26🟢 Lean-Bull · 13F 13+/10-×0.5 · short↓0.15
Snapshot · 7/31/26